Production (Stage)
Rani Therapeutics Holdings, Inc.
RANI
$0.5289
-$0.031-5.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.85M | 27.64M | 30.40M | 30.90M | 39.58M |
| Total Receivables | 600.00K | 428.00K | -- | 100.00K | 166.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 830.00K | 1.18M | 1.47M | 533.00K | 1.14M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 500.00K | 500.00K | 500.00K | 500.00K | 500.00K |
| Total Current Assets | 17.78M | 29.74M | 32.37M | 32.03M | 41.39M |
|
|
|||||
| Total Current Assets | 17.78M | 29.74M | 32.37M | 32.03M | 41.39M |
| Net Property, Plant & Equipment | 6.10M | 6.64M | 10.92M | 11.45M | 11.88M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 246.00K | 246.00K | 246.00K | 246.00K | 246.00K |
| Total Assets | 24.13M | 36.63M | 43.54M | 43.73M | 53.51M |
|
|
|||||
| Total Accounts Payable | 1.52M | 1.36M | 1.57M | 506.00K | 806.00K |
| Total Accrued Expenses | 1.98M | 1.79M | 1.68M | 1.89M | 2.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.33M | 16.46M | 16.18M | 13.65M | 9.81M |
| Total Finance Division Other Current Liabilities | 310.00K | 283.00K | 783.00K | 534.00K | 564.00K |
| Total Other Current Liabilities | 310.00K | 283.00K | 783.00K | 534.00K | 564.00K |
| Total Current Liabilities | 20.13M | 19.89M | 20.21M | 16.58M | 13.38M |
|
|
|||||
| Total Current Liabilities | 20.13M | 19.89M | 20.21M | 16.58M | 13.38M |
| Long-Term Debt | 5.92M | 9.61M | 13.54M | 17.21M | 20.85M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.42M | 3.64M | 4.02M | 4.39M | 4.75M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 29.47M | 33.14M | 37.77M | 38.18M | 38.98M |
|
|
|||||
| Common Stock & APIC | 107.11M | 104.89M | 97.07M | 90.02M | 87.78M |
| Retained Earnings | -110.17M | -102.91M | -93.96M | -87.18M | -80.37M |
| Treasury Stock & Other | 2.00K | 5.00K | 8.00K | -5.00K | -11.00K |
| Total Common Equity | -3.06M | 1.99M | 3.12M | 2.84M | 7.40M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.06M | 1.99M | 3.12M | 2.84M | 7.40M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -2.29M | 1.50M | 2.66M | 2.72M | 7.14M |
| Total Equity | -5.35M | 3.49M | 5.78M | 5.55M | 14.54M |
|
|
|||||